Trump’s Back, but DC’s Coming for Your Money!

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

CUE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.26%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Cue Biopharma Insider Trading History Chart

Cue Biopharma Share Price & Price History

^$1.25

▼ -0.25 (-16.72%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

2024's Must-Watch Stocks!

From Darwin | Ad

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Unlock Your Report Now]

Cue Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/25/2023	Anish Suri	Insider	Buy	4,000	$2.76	$11,040.00	135,638
8/14/2023	Daniel R. Passeri	CEO	Buy	3,000	$2.86	$8,580.00	134,578
3/23/2023	Peter A Kiener	Director	Sell	9,325	$3.28	$30,586.00	357
5/23/2022	Aaron G.L. Fletcher	Director	Buy	150,000	$3.52	$528,000.00	885,000
3/31/2022	Aaron G.L. Fletcher	Director	Buy	735,000	$4.76	$3,498,600.00	165,000

Unveiled: NVIDIA’s "Secret Royalty" Program

From Behind the Markets | Ad

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>

SEC Filings (Institutional Ownership Changes) for Cue Biopharma (NASDAQ:CUE)

35.04% of Cue Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cue Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	508,827	$0.39M	0.0%	+3.3%	1.046%
11/5/2024	GSA Capital Partners LLP	291,663	$0.22M	0.0%	+5.1%	0.600%
11/4/2024	Sigma Planning Corp	401,325	$0.30M	0.0%	+50.9%	0.825%
10/16/2024	Good Life Advisors LLC	400,000	$0.30M	0.0%	+23.1%	0.822%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	53,027	$66K	0.0%	N/A	0.109%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	53,027	$66K	0.0%	N/A	0.109%
8/9/2024	Dimensional Fund Advisors LP	214,089	$0.27M	0.0%	-50.4%	0.440%
8/7/2024	Monaco Asset Management SAM	253,185	$0.31M	0.1%	-24.4%	0.521%
5/14/2024	Carlson Capital L P	20,000	$38K	0.0%	-83.3%	0.041%
5/10/2024	Vanguard Group Inc.	2,283,362	$4.32M	0.0%	+7.1%	4.694%
5/9/2024	Monaco Asset Management SAM	334,742	$0.63M	0.2%	-2.2%	0.688%
4/10/2024	Wedmont Private Capital	40,000	$76K	0.0%	+100.0%	0.082%
2/8/2024	Legacy Capital Group California Inc.	10,000	$26K	0.0%	N/A	0.022%
2/7/2024	Monaco Asset Management SAM	342,242	$0.90M	0.3%	-4.9%	0.759%
2/1/2024	Sigma Planning Corp	108,875	$0.29M	0.0%	-55.5%	0.241%
1/18/2024	Navalign LLC	25,000	$66K	0.0%	N/A	0.055%
1/18/2024	Good Life Advisors LLC	100,000	$0.26M	0.0%	-10.7%	0.222%
11/7/2023	Monaco Asset Management SAM	359,739	$0.83M	0.2%	-2.9%	0.800%
11/7/2023	New York State Common Retirement Fund	11,984	$28K	0.0%	-53.4%	0.027%
11/6/2023	Sigma Planning Corp	244,705	$0.56M	0.0%	+8.6%	0.544%
10/24/2023	Channel Wealth LLC	15,300	$35K	0.0%	-77.7%	0.034%
10/13/2023	Sanders Morris Harris LLC	346,212	$0.80M	0.2%	+513.6%	0.770%
9/21/2023	Barclays PLC	12,946	$48K	0.0%	+114.7%	0.029%
8/15/2023	Silverarc Capital Management LLC	403,402	$1.47M	0.5%	+31.7%	0.897%
8/10/2023	Carlson Capital L P	134,036	$0.49M	0.0%	-47.2%	0.310%
8/8/2023	Monaco Asset Management SAM	370,407	$1.35M	0.4%	-20.6%	0.858%
8/4/2023	American International Group Inc.	16,635	$61K	0.0%	N/A	0.039%
8/2/2023	Sigma Planning Corp	225,300	$0.82M	0.0%	+2.0%	0.522%
7/27/2023	Virtu Financial LLC	17,594	$64K	0.0%	N/A	0.041%
7/26/2023	Channel Wealth LLC	68,700	$0.25M	0.1%	+14.4%	0.159%
7/13/2023	Cambridge Investment Research Advisors Inc.	20,000	$73K	0.0%	N/A	0.046%
7/11/2023	Sanders Morris Harris LLC	56,420	$0.20M	0.0%	N/A	0.131%
5/12/2023	Prosight Management LP	1,151,855	$4.11M	1.9%	-37.4%	2.668%
5/8/2023	Sigma Planning Corp	220,889	$0.79M	0.0%	+14.6%	0.512%
5/1/2023	P.A.W. Capital Corp	150,000	$0.54M	1.2%	-16.7%	0.347%
4/27/2023	Channel Wealth LLC	60,050	$0.21M	0.1%	N/A	0.139%
4/18/2023	ETF Managers Group LLC	13,528	$48K	0.0%	N/A	0.031%
2/13/2023	Voss Capital LLC	125,000	$0.36M	0.1%	-37.5%	0.290%
2/13/2023	GSA Capital Partners LLP	188,308	$0.54M	0.1%	-12.9%	0.438%
2/10/2023	Good Life Advisors LLC	75,000	$0.21M	0.0%	+31.6%	0.174%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	22,970	$65K	0.0%	-29.7%	0.053%
2/3/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
2/1/2023	Bank of Montreal Can	33,900	$98K	0.0%	N/A	0.079%
1/31/2023	Monaco Asset Management SAM	497,177	$1.42M	0.4%	+8.4%	1.155%
1/24/2023	Sigma Planning Corp	192,734	$0.55M	0.0%	+2.3%	0.448%
1/13/2023	Sanders Morris Harris LLC	56,420	$0.16M	0.1%	-93.3%	0.131%
11/15/2022	Prosight Management LP	1,545,573	$3.45M	1.8%	-6.6%	4.368%
11/15/2022	Carlson Capital L P	535,000	$1.19M	0.1%	-7.8%	1.512%
11/14/2022	Annandale Capital LLC	65,000	$0.15M	0.1%	N/A	0.184%
11/14/2022	Ergoteles LLC	117,074	$0.26M	0.0%	-14.2%	0.331%
11/10/2022	Sigma Planning Corp	188,424	$0.42M	0.0%	+12.8%	0.533%
11/10/2022	Nantahala Capital Management LLC	93,297	$0.21M	0.0%	-7.1%	0.264%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	32,677	$73K	0.0%	N/A	0.092%
11/2/2022	Voss Capital LLC	200,000	$0.45M	0.1%	+100.0%	0.565%
11/1/2022	P.A.W. Capital Corp	200,000	$0.45M	0.7%	+14.3%	0.565%
10/31/2022	Monaco Asset Management SAM	458,851	$1.02M	0.4%	+3.4%	1.297%
10/13/2022	Newbridge Financial Services Group Inc.	17,000	$38K	0.0%	+41.7%	0.048%
10/7/2022	Sanders Morris Harris LLC	848,048	$2.02M	0.5%	+15.2%	2.397%
8/16/2022	Delphia USA Inc.	10,126	$25K	0.0%	N/A	0.029%
8/15/2022	Nantahala Capital Management LLC	100,464	$0.25M	0.0%	-95.5%	0.284%
8/13/2022	Voss Capital LLC	100,000	$0.25M	0.1%	N/A	0.283%
8/13/2022	Prosight Management LP	1,655,477	$4.12M	3.2%	+9.6%	4.679%
8/12/2022	Ensign Peak Advisors Inc	17,960	$45K	0.0%	+72.7%	0.051%
8/11/2022	Sigma Planning Corp	167,106	$0.42M	0.0%	+28.8%	0.472%
8/1/2022	Monaco Asset Management SAM	443,851	$1.11M	0.5%	+886.3%	1.255%
7/19/2022	Good Life Advisors LLC	57,000	$0.14M	0.0%	N/A	0.161%
7/15/2022	Newbridge Financial Services Group Inc.	12,000	$30K	0.0%	+200.0%	0.034%
7/13/2022	P.A.W. Capital Corp	175,000	$0.44M	0.6%	+16.7%	0.495%
7/11/2022	Sanders Morris Harris LLC	736,212	$1.80M	0.4%	-15.7%	2.081%
6/30/2022	Amalgamated Bank	5,025	$25K	0.0%	N/A	0.014%
5/17/2022	Prosight Management LP	1,510,282	$7.37M	4.8%	+82.2%	4.270%
5/11/2022	Bleichroeder LP	552,000	$2.69M	0.5%	+176.0%	1.672%
5/11/2022	GSA Capital Partners LLP	96,563	$0.47M	0.1%	-3.3%	0.293%
5/9/2022	WealthShield Partners LLC	29,951	$0.15M	0.0%	+161.7%	0.091%
5/9/2022	Monaco Asset Management SAM	45,000	$0.22M	0.1%	N/A	0.136%
5/4/2022	Advisor Group Holdings Inc.	38,182	$2.41M	0.0%	+43.4%	0.116%
4/21/2022	Virginia Retirement Systems ET AL	11,000	$54K	0.0%	-31.3%	0.033%
4/21/2022	P.A.W. Capital Corp	150,000	$0.73M	0.8%	+25.0%	0.454%
4/20/2022	Sigma Planning Corp	129,728	$0.63M	0.0%	+51.0%	0.393%
4/11/2022	Sanders Morris Harris LLC	873,021	$4.26M	0.8%	+143.1%	2.645%
2/14/2022	GSA Capital Partners LLP	99,816	$1.13M	0.1%	-18.0%	0.314%
2/11/2022	Granite Point Capital Management L.P.	110,000	$1.24M	0.2%	N/A	0.346%
2/11/2022	Ensign Peak Advisors Inc	10,400	$0.12M	0.0%	N/A	0.033%
2/10/2022	Bleichroeder LP	200,000	$2.26M	0.4%	+14.3%	0.630%
2/10/2022	Rafferty Asset Management LLC	97,062	$1.10M	0.0%	+148.8%	0.306%
2/10/2022	WealthShield Partners LLC	11,444	$0.13M	0.0%	-38.5%	0.036%
2/10/2022	Citigroup Inc.	80,185	$0.91M	0.0%	+184.3%	0.252%
2/10/2022	P.A.W. Capital Corp	120,000	$1.36M	1.2%	-4.0%	0.378%
2/9/2022	BNP Paribas Arbitrage SA	21,294	$0.24M	0.0%	+277.9%	0.067%
2/9/2022	Dimensional Fund Advisors LP	849,343	$9.61M	0.0%	+360.1%	2.674%
2/8/2022	Northern Trust Corp	316,467	$3.58M	0.0%	+2.2%	0.996%
2/3/2022	Advisor Group Holdings Inc.	26,620	$0.30M	0.0%	-14.7%	0.084%
2/3/2022	Virginia Retirement Systems ET AL	16,000	$0.18M	0.0%	+29.0%	0.050%
2/2/2022	Sanders Morris Harris LLC	359,113	$4.42M	0.8%	+17.5%	1.131%
2/2/2022	Sigma Planning Corp	85,893	$0.97M	0.0%	+2.0%	0.270%
1/25/2022	Belvedere Trading LLC	19,819	$0.18M	0.0%	N/A	0.062%
11/16/2021	Two Sigma Advisers LP	202,000	$2.94M	0.0%	-32.2%	0.636%
11/16/2021	Two Sigma Investments LP	103,430	$1.51M	0.0%	-48.5%	0.326%
11/15/2021	California State Teachers Retirement System	39,229	$0.57M	0.0%	-4.5%	0.124%
11/15/2021	Marshall Wace LLP	26,340	$0.38M	0.0%	-16.8%	0.083%

Data available starting January 2016

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $1.25

$1.24

$1.56

50 Day Range

MA: $1.14

$0.45

$1.87

52 Week Range

Now: $1.25

$0.45

$3.25

Volume

1,208,865 shs

Average Volume

927,016 shs

Market Capitalization

$60.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Who are the company insiders with the largest holdings of Cue Biopharma?: Cue Biopharma's top insider investors include:
Anish Suri (Insider)
Daniel R Passeri (CEO)
Peter A Kiener (Director)
Learn More about top insider investors at Cue Biopharma.
Who are the major institutional investors of Cue Biopharma?: Cue Biopharma's top institutional investors include:
Geode Capital Management LLC — 1.05%
Sigma Planning Corp — 0.83%
Good Life Advisors LLC — 0.82%
GSA Capital Partners LLP — 0.60%
Learn More about top institutional investors of Cue Biopharma stock.
Which institutional investors are buying Cue Biopharma stock?: In the last quarter, CUE stock was bought by institutional investors including:
Sigma Planning Corp
Good Life Advisors LLC
Geode Capital Management LLC
GSA Capital Partners LLP
Within the last year, these company insiders have bought Cue Biopharma stock:
Anish Suri (Insider)
Daniel R Passeri (CEO)
Learn More investors buying Cue Biopharma stock.